Zydus Recalls Benzonatate Capsules Due to Foreign Capsule Contamination
Zydus Pharmaceuticals USA is recalling Benzonatate 200 mg capsules because they may contain foreign 100 mg capsules.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The FDA classified this as a Class III recall, which by definition is unlikely to cause adverse health consequences, fitting the 'Low' severity criteria for minor or theoretical risks.
Plain-English summary
Zydus Pharmaceuticals USA, Inc. is recalling Benzonatate Capsules, USP, 200 mg, 100 Capsule Bottles. The recall is due to the presence of foreign capsules, specifically Benzonatate 100 mg capsules, co-mingled with the 200 mg capsules.
The affected product is distributed by Zydus Pharmaceuticals USA, Inc. and manufactured by Cadila Healthcare Ltd, Ahmedabad, India. The recall covers 63,648 bottles distributed nationwide in the United States, including Puerto Rico. The affected lots are MM8555, MM6604, MM8551, MM8552, MM8553, and MM8554, all with an expiration date of 09/14.
Consumers and healthcare providers should check their inventory for these specific lot numbers and stop using the product if it matches the description. The FDA has classified this as a Class III recall, indicating that the product is not likely to cause adverse health consequences.
The recalled product
- Product
- BENZONATATE Capsules, USP, 200 mg, 100 Capsule Bottles, Rx only. Manufactured by: Cadila Healthcare Ltd, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA, Inc. NDC: 68382-248-01
- Manufacturer
- Zydus Pharmaceuticals USA Inc
- Category
- Drug — Prescription Medication
- Affected units
- 63,648
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (8)
- Lot #: MM8555
- Expiry: 09/14
- Lot #: MM6604
- Lot #: MM8551
- Lot #: MM8552
- Lot #: MM8553
- Lot #: MM8554
- Expiry: 09/14.
Distribution
Related recalls
Same manufacturer · Zydus Pharmaceuticals USA Inc
See all →- SevereFDA Recalls Mirabegron Tablets Over Nitrosamine Impurity
FDA (Drugs) · 2026-08-12
- SevereErythromycin Tablets Recalled for Impurity Above Acceptable Limits
FDA (Drugs) · 2026-05-27
- SevereErythromycin 500 mg Tablets Recalled for Impurity Above Limits
FDA (Drugs) · 2026-05-27
- HighIcosapent ethyl capsules recalled after active ingredient oxidized inside capsule
FDA (Drugs) · 2026-03-18
- HighIcosapent ethyl capsules recalled as subpotent after capsule contents leaked
FDA (Drugs) · 2026-01-28
Same hazard · foreign object
See all →- SevereOutshine Strawberry Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Black Cherry Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Fruit Bars Grape Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Watermelon Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02